Network meta-analysis of 20 NSAIDs in treatment of anyklosing spondylitis .
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Comparative efficacy of non-steroidal anti-inflammatory drugs in ankylosing spondylitis: a Bayesian network meta-analysis of clinical trials
Ann Rheum Dis. 2016 Jun;75(6):1152-6026 randomized controlled trials were included in this network meta-analysis on the comparative efficacy of 20 different non-steroidal anti-inflammatory drugs in patients with ankylosing spondylitis. In total, 15 of the 20 NSAIDs demonstrated a significant effect on short-term pain compared to placebo. The greatest effect size was observed with etoricoxib use, which also demonstrated significantly greater efficacy compared to celecoxib, ketoprofen, and tenoxicam. Only sulindac demonstrated a statistically significant increase in the incidence of gastrointestinal adverse events compared to placebo.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics